» Authors » Yuan-Liang Wang

Yuan-Liang Wang

Explore the profile of Yuan-Liang Wang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 756
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng F, Li Y, Zhang F, Sun Y, Zheng C, Luo Z, et al.
J Hazard Mater . 2024 Nov; 481():136590. PMID: 39572344
No abstract available.
2.
Wu Z, Chen X, Ma H, Li K, Wang Y, Li Z
Nutrients . 2023 Apr; 15(7). PMID: 37049564
To explore the mechanism by which cell-free supernatant improves glucose and lipid metabolisms in , the present study used different dilution concentrations of cell-free supernatant as an intervention for with...
3.
Chen C, Li H, Wang Y, Lee C, Shen Y, Hsieh C, et al.
Sci Rep . 2022 Sep; 12(1):16399. PMID: 36180511
Malignant brain tumors consist of malignancies originated primarily within the brain and the metastatic lesions disseminated from other organs. In spite of intensive studies, malignant brain tumors remain to be...
4.
Lyu Y, Yang S, Lyu X, Wang Y, Ji S, Kang S, et al.
World J Surg Oncol . 2022 Aug; 20(1):273. PMID: 36045445
Background: Previous studies have found that lncRNA polymorphisms are associated with the prognosis of gastric cancer (GC), but the specific roles of many lncRNA polymorphism sites in gastric cancer are...
5.
Liu L, Shen Y, Wang Y, Wu W, Chang L, Chen Y, et al.
Front Oncol . 2022 Aug; 12:851795. PMID: 35992877
The cGAS-STING axis is one of the key mechanisms guarding cells from pathogen invasion in the cytoplasmic compartment. Sensing of foreign DNA in the cytosol by the cGAS-STING axis triggers...
6.
Wang Y, Wu W, Lin P, Shen Y, Lin Y, Li H, et al.
Int J Mol Sci . 2022 May; 23(10). PMID: 35628489
Invasion is the most prominent lethal feature of malignant cancer. However, how cell proliferation, another important feature of tumor development, is integrated with tumor invasion and the subsequent cell dissemination...
7.
Zheng F, Luo Z, Lin X, Wang W, Aschner M, Cai P, et al.
Nanotoxicology . 2022 Jan; 15(10):1358-1379. PMID: 35077651
Broad applications of cobalt nanoparticles (CoNPs) have raised increased concerns regarding their potential toxicity. However, the underlining mechanisms of their toxicity have yet to be characterized. Here, we demonstrated that...
8.
Lin Y, Liu S, Wu W, Shen Y, Wang Y, Liao C, et al.
Comput Struct Biotechnol J . 2022 Jan; 20:241-251. PMID: 35024096
Programmed cell death protein 1 (PD-1)/ programmed cell death protein ligand 1 (PD-L1) is the key immune checkpoint governing evasion of advanced cancer from immune surveillance. Immuno-oncology (IO) therapy targeting...
9.
Lin Y, Lee C, Cho D, Wang Y, Chen C, Weng C, et al.
Am J Cancer Res . 2021 Oct; 11(9):4455-4469. PMID: 34659898
Anti-estrogens as hormone therapy are the mainstay treatment for estrogen receptor (ER)-positive breast cancer. ER inhibitors through modulating the transcriptional function of ER have been the frontline anti-estrogens to which...
10.
Yang S, Wang Y, Lyu Y, Jiang Y, Xiang J, Ji S, et al.
Cancer Metab . 2021 Sep; 9(1):34. PMID: 34565479
Background: Metabolite genome-wide association studies (mGWAS) are key for understanding the genetic regulation of metabolites in complex diseases including cancers. Although mGWAS has revealed hundreds of metabolomics quantitative trait loci...